Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy.
Gao LR, Li C, Han W, Ni W, Deng W, Tan L, Zhou Z, Chen D, Feng Q, Liang J, Lv J, Wang W, Liu W, Deng L, Wang X, Zhang T, Wang J, Zhai Y, Bi N, Wang L, Hui Z, Li YX, Xiao Z.
Gao LR, et al. Among authors: tan l.
Ther Adv Med Oncol. 2022 Jul 26;14:17588359221108693. doi: 10.1177/17588359221108693. eCollection 2022.
Ther Adv Med Oncol. 2022.
PMID: 35923925
Free PMC article.